세계의 변실금 시장 보고서(2025년)
Fecal Incontinence Global Market Report 2025
상품코드 : 1730857
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,673,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,645,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,617,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 변실금 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 이 기간의 주요 동향에는 기술의 진보, 맞춤형 의료 어프로치의 채용, 생분해성으로 에코 친화적 제품에 대한 수요 증가, 전기 자극 장치나 흡수성 강화 제품 등의 혁신, 디지털 헬스 기술의 통합 등이 있습니다.

위장장애의 유병률 증가는 대변실금 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질환은 가공식품의 다량 섭취나 식이섬유 섭취량이 적은 식생활의 혼란과 라이프 스타일의 변화와 관련이 있습니다. 예를 들어, 2023년 6월, Crohn's and Colitis Canada는 IBD 환자수가 2023년의 32만 2,600명(인구의 0.8%)에서 2035년에는 47만명(인구의 1.1%)으로 증가할 것으로 예측했습니다. 또한 2023년에는 1만 1,000명의 신규 사례가 예상되어 2035년에는 1만 4,000명으로 증가할 것으로 예측되고 있습니다.

변실금 시장의 기업은 환자의 편안함을 개선하고, 치료 성과를 높이고, 시장에서의 존재를 확대하기 위해 골반 건강 시스템과 같은 혁신적인 솔루션을 개발하고 있습니다. 골반 건강 시스템이란 골반내의 장기나 구조의 진단, 관리, 건강증진을 목적으로 한 다양한 의료기술, 서비스, 치료를 말합니다. 이 시스템은 요실금, 골반 통증, 재생산 건강 문제 등 골반 바닥의 상태를 해결하도록 설계되었습니다. 예를 들어, 2023년 6월, 미국 의료기기 회사인 Axena Health Inc.는 미국 식품의약국의 인가를 받은 골반건강시스템 'Leva'를 발매했습니다. 이 시스템은 모션 센서와 실시간 피드백을 사용하여 골반저근을 강화하는 비침습적이고 약물을 사용하지 않는 방법을 제공하며 사용자를 매일 5분간 운동으로 안내합니다. 원격 의료와의 통합으로 이 시스템은 특히 변실금을 대상으로 하며 환자에게 유용하고 효과적인 솔루션을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Fecal incontinence is the involuntary loss of bowel control, resulting in the unintentional passing of stool or gas. It can range from occasional stool leakage while passing gas to a complete inability to control bowel movements. Causes can include damage to muscles or nerves, diarrhea, constipation, or underlying medical conditions such as inflammatory bowel disease or neurological disorders.

The primary product types for managing fecal incontinence include absorbent products, anal inserts, electrical stimulation devices, and other related items. Absorbent products help control fecal incontinence by preventing leaks and providing comfort. These products are used by various age groups, including pediatric, adult, and elderly populations, and are applied in hospitals, clinics, home care environments, and other settings. They are available through a variety of distribution channels, such as online stores, pharmacies, specialty stores, and more.

The fecal incontinence market research report is one of a series of new reports from The Business Research Company that provides fecal incontinence market statistics, including the fecal incontinence industry global market size, regional shares, competitors with the fecal incontinence market share, detailed fecal incontinence market segments, market trends, and opportunities, and any further data you may need to thrive in the fecal incontinence industry. This fecal incontinence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal incontinence market size has grown strongly in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to factors such as the rising incidence of injuries or trauma, the increasing prevalence of gastrointestinal disorders, higher healthcare spending, an aging population, the adoption of anti-diarrheal medications, and the expanding availability of treatment and management products.

The fecal incontinence market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of chronic diarrhea, higher demand for minimally invasive procedures, favorable reimbursement policies, the growing popularity of sacral nerve stimulation techniques, and rising investments in research and development. Key trends during this period include technological advancements, the adoption of personalized medicine approaches, a rising demand for biodegradable and eco-friendly products, innovations such as electrical stimulation devices and enhanced absorbent products, and the integration of digital health technologies.

The growing prevalence of gastrointestinal disorders is expected to drive the growth of the fecal incontinence market. Gastrointestinal (GI) disorders affect the digestive system, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. The increase in these disorders is linked to poor dietary habits and lifestyle changes, such as a high intake of processed foods and low fiber consumption. Conditions such as inflammatory bowel disease (IBD), chronic diarrhea, and irritable bowel syndrome (IBS) can lead to fecal incontinence by disrupting bowel function in various ways. For example, in June 2023, Crohn's and Colitis Canada reported that the number of people living with IBD is projected to grow from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). Additionally, 11,000 new cases were expected in 2023, with projections increasing to 14,000 new cases by 2035. This rise in gastrointestinal disorders is driving the growth of the fecal incontinence market.

Companies in the fecal incontinence market are developing innovative solutions such as pelvic health systems to improve patient comfort, enhance treatment outcomes, and expand their market presence. A pelvic health system refers to various medical technologies, services, and treatments aimed at diagnosing, managing, and improving the health of pelvic organs and structures. These systems are designed to address pelvic floor conditions, including incontinence, pelvic pain, and reproductive health issues. For example, in June 2023, Axena Health Inc., a US-based medical device company, launched the Leva pelvic health system, which received U.S. Food and Drug Administration clearance. This system offers a non-invasive, drug-free method to strengthen pelvic floor muscles using motion sensors and real-time feedback, guiding users through five-minute daily exercises. With telehealth integration, the system specifically targets fecal incontinence, providing an accessible and effective solution for patients.

In January 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Axonics Inc. for $3.7 billion. This acquisition aims to enhance Boston Scientific's urology portfolio by incorporating Axonics' innovative technologies for treating urinary and bowel dysfunction. Axonics specializes in neuromodulation solutions for conditions such as overactive bladder (OAB), fecal incontinence, and urinary retention.

Major players in the fecal incontinence market are 3M Company, Medtronic plc, Medline Industries LP, Essity AB, B. Braun Melsungen AG, Domtar Corporation, Coloplast Corp., HARTMANN Direct, ConvaTec Group plc, Ontex Group NV, Hollister Incorporated, Abena Group, Laborie Medical Technologies, Home Care Delivered, 180 Medical, Attends Healthcare Products Inc., Principle Business Enterprises Inc., Carewell, NorthShore Care Supply, InControl Medical, Tranquility Products, Aeroflow Urology, Reliance Medical Inc., TZMO SA, and Allegro Medical.

North America was the largest region in the fecal incontinence market in 2024. The regions covered in fecal incontinence report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fecal incontinence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal incontinence market consists of revenues earned by entities by providing services such as medical treatments, pelvic floor rehabilitation, surgical interventions, consultation, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal incontinence market also includes sales of bowel management systems, anti-diarrheal drugs, laxatives, stool softeners, artificial sphincters, and nerve stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Incontinence Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal incontinence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for fecal incontinence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal incontinence market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Fecal Incontinence Market Characteristics

3. Fecal Incontinence Market Trends And Strategies

4. Fecal Incontinence Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Fecal Incontinence Growth Analysis And Strategic Analysis Framework

6. Fecal Incontinence Market Segmentation

7. Fecal Incontinence Market Regional And Country Analysis

8. Asia-Pacific Fecal Incontinence Market

9. China Fecal Incontinence Market

10. India Fecal Incontinence Market

11. Japan Fecal Incontinence Market

12. Australia Fecal Incontinence Market

13. Indonesia Fecal Incontinence Market

14. South Korea Fecal Incontinence Market

15. Western Europe Fecal Incontinence Market

16. UK Fecal Incontinence Market

17. Germany Fecal Incontinence Market

18. France Fecal Incontinence Market

19. Italy Fecal Incontinence Market

20. Spain Fecal Incontinence Market

21. Eastern Europe Fecal Incontinence Market

22. Russia Fecal Incontinence Market

23. North America Fecal Incontinence Market

24. USA Fecal Incontinence Market

25. Canada Fecal Incontinence Market

26. South America Fecal Incontinence Market

27. Brazil Fecal Incontinence Market

28. Middle East Fecal Incontinence Market

29. Africa Fecal Incontinence Market

30. Fecal Incontinence Market Competitive Landscape And Company Profiles

31. Fecal Incontinence Market Other Major And Innovative Companies

32. Global Fecal Incontinence Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fecal Incontinence Market

34. Recent Developments In The Fecal Incontinence Market

35. Fecal Incontinence Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기